Carbamazepine extended-release [Equetro] for the treatment of bipolar depression.
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2018
At a glance
- Drugs Carbamazepine (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions; Therapeutic Use
- 26 Jun 2008 Status changed from recruiting to completed.
- 19 Nov 2005 New trial record.